Skip to content
XP
Asset Manager

Updated:

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a pharmaceutical company based in Chicago, United States, founded in 2005. It develops and commercializes ready-to-use,...

Overview

Xeris Pharmaceuticals is a pharmaceutical company based in Chicago, United States, founded in 2005. It develops and commercializes ready-to-use, liquid-stable injectables using its novel formulation technology platforms. The company has secured $115.5 million in total funding.

General information

Firm type

Biopharmaceutical

Year founded

2005

Location

Region

Asia

Country

Japan

City

Tokyo

Corporate office

Tokyo, Japan

Additional offices

Chicago, United States

Sector focus

PharmaceuticalsBiotechHealthcare Services

Frequently asked questions

How is Xeris Pharmaceuticals structured?

Public records indicate the firm operates from Japan and the United States, but its legal structure — whether as a family office, asset manager, or holding company — is not specified in available sources.

Who are the key principals at Xeris Pharmaceuticals?

No named principals or leadership team members for Xeris Pharmaceuticals are available in public sources. The firm's management structure remains undisclosed.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Biopharmaceutical profiles